Published in Cochrane Database Syst Rev on July 02, 2015
Self-Reported Fatigue and Associated Factors Six Years after Stroke. PLoS One (2016) 0.78
Clinical Utility of Mindfulness Training in the Treatment of Fatigue After Stroke, Traumatic Brain Injury and Multiple Sclerosis: A Systematic Literature Review and Meta-analysis. Front Psychol (2016) 0.76
MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial. Stroke (2017) 0.75
Exploratory Cohort Study of Associations between Serum C - Reactive Protein and Fatigue after Stroke. PLoS One (2015) 0.75
Influence of Medication on Fatigue Six Months after Stroke. Stroke Res Treat (2016) 0.75
Development of a psychological intervention for fatigue after stroke. PLoS One (2017) 0.75
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
Psychological medicine and the future of psychiatry. Br J Psychiatry (2014) 4.48
Exercise for depression. Cochrane Database Syst Rev (2013) 4.30
Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ (2005) 4.25
Motor recovery after stroke: a systematic review. Lancet Neurol (2009) 4.23
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2002) 3.93
Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet (2008) 3.79
Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56
Somatic symptom disorder: an important change in DSM. J Psychosom Res (2013) 3.40
Chronic fatigue syndrome: a step towards agreement. Lancet (2002) 2.99
Physical fitness training for stroke patients. Cochrane Database Syst Rev (2009) 2.95
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke (2002) 2.83
Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry (2005) 2.81
Improving the translational hit of experimental treatments in multiple sclerosis. Mult Scler (2010) 2.73
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
Are electronic diaries useful for symptoms research? A systematic review. J Psychosom Res (2007) 2.66
What are the components of effective stroke unit care? Age Ageing (2002) 2.46
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ (2008) 2.43
Stroke. Lancet (2003) 2.40
What should we say to patients with symptoms unexplained by disease? The "number needed to offend". BMJ (2002) 2.20
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst (2008) 2.17
Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis (2009) 2.12
Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med (2014) 2.05
Do acute phase markers explain body temperature and brain temperature after ischemic stroke? Neurology (2012) 2.03
Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol (2009) 1.98
Organising care for chronic illness. BMJ (2002) 1.95
Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing (2011) 1.94
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke (2004) 1.91
Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys (2003) 1.89
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol (2008) 1.80
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials (2008) 1.79
Exercise for depression. Cochrane Database Syst Rev (2012) 1.78
Eliot Slater's myth of the non-existence of hysteria. J R Soc Med (2005) 1.78
Rasch fit statistics and sample size considerations for polytomous data. BMC Med Res Methodol (2008) 1.77
Is there a better term than "medically unexplained symptoms"? J Psychosom Res (2010) 1.77
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev (2012) 1.72
Diffusion-weighted imaging and diagnosis of transient ischemic attack. Ann Neurol (2014) 1.72
Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys (2004) 1.70
Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord (2011) 1.64
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med (2009) 1.63
Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics (2007) 1.63
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62
Somatoform disorders in DSM-V. Psychosomatics (2003) 1.62
Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry (2012) 1.57
Somatoform disorders-new approaches to classification, conceptualization, and treatment. J Psychosom Res (2004) 1.53
Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis (2011) 1.53
Effects of introducing an integrated care pathway in an acute stroke unit. Age Ageing (2004) 1.52
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials (2011) 1.49
Better off dead: suicidal thoughts in cancer patients. J Clin Oncol (2008) 1.46
A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab (2009) 1.45
Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.42
Surveying the literature from animal experiments: systematic review and meta-analysis are important contributions. BMJ (2005) 1.38
Predictors of upper limb recovery after stroke: a systematic review and meta-analysis. Clin Rehabil (2011) 1.37
Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism. J Cereb Blood Flow Metab (2010) 1.35
Interventions for improving upper limb function after stroke. Cochrane Database Syst Rev (2014) 1.34
Treatment of intracerebral hemorrhage in animal models: meta-analysis. Ann Neurol (2011) 1.26
Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res (2007) 1.24
Animal models of bone cancer pain: systematic review and meta-analyses. Pain (2013) 1.22
Fatigue after stroke: the development and evaluation of a case definition. J Psychosom Res (2007) 1.20
The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke (2011) 1.19
Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice. Br J Pharmacol (2009) 1.18
Healthcare costs incurred by patients repeatedly referred to secondary medical care with medically unexplained symptoms: a cost of illness study. J Psychosom Res (2012) 1.17
Evaluation of fatigue scales in stroke patients. Stroke (2007) 1.17
The microcirculation as a functional system. Crit Care (2005) 1.16
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke (2014) 1.13
Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med (2011) 1.13
A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovasc Dis (2007) 1.13
Greater incidence of both fatal and nonfatal strokes in disadvantaged areas: the Northeast Melbourne Stroke Incidence Study. Stroke (2006) 1.13
Preclinical studies of human disease: time to take methodological quality seriously. J Mol Cell Cardiol (2011) 1.13
Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke (2012) 1.11
Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev (2010) 1.10
Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesth (2011) 1.10
Improving adherence to medication in stroke survivors: a pilot randomised controlled trial. Ann Behav Med (2013) 1.09
A history of liaison psychiatry in the UK. BJPsych Bull (2016) 1.08
La belle indifférence in conversion symptoms and hysteria: systematic review. Br J Psychiatry (2006) 1.08
Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci (2007) 1.07
Stroke liaison workers for stroke patients and carers: an individual patient data meta-analysis. Cochrane Database Syst Rev (2010) 1.06
Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol (2010) 1.06
Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst Rev (2013) 1.05
FMRI in patients with motor conversion symptoms and controls with simulated weakness. Psychosom Med (2007) 1.05
Interventions for post-stroke fatigue. Cochrane Database Syst Rev (2009) 1.04
Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer (2010) 1.03
Integrating psychosocial care into cancer services. J Clin Oncol (2012) 1.02
Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing. J Cereb Blood Flow Metab (2010) 1.02
The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice. BMC Med (2015) 1.01
Variations in quality indicators of acute stroke care in 6 European countries: the European Implementation Score (EIS) Collaboration. Stroke (2011) 1.01
Door-to-needle time and the proportion of patients receiving intravenous thrombolysis in acute ischemic stroke: uniform interpretation and reporting. Stroke (2013) 1.01
Thoughts of death and suicide reported by cancer patients who endorsed the "suicidal thoughts" item of the PHQ-9 during routine screening for depression. Psychosomatics (2011) 1.01